Señales en vivo de ISOFOL.ST | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 11:21):

Stats
Volumen de hoy	872 145
Volumen promedio	538 648
Capitalización de mercado	112.09M
EPS	SEK0 ( 2024-02-19 )
Próxima fecha de ganancias	( SEK0 ) 2024-05-07
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-3.02
ATR14	SEK0.00800 (1.15%)

Volumen Correlación

Largo: 0.03 (neutral)

Corto: 0.37 (neutral)

Signal:(53.202) Neutral

Isofol Medical AB (publ) Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Isofol Medical AB (publ) Correlación - Moneda/Commodity

0.35
( neutral )

0.03
( neutral )

0.00
( neutral )

0.19
( neutral )

0.00
( neutral )

0.11
( neutral )

Isofol Medical AB (publ) Finanzas

Annual	2023
Ingresos:	SEK721 000
Beneficio Bruto:	SEK-41.88M (-5 808.04 %)
EPS:	SEK-0.230

FY	2023
Ingresos:	SEK721 000
Beneficio Bruto:	SEK-41.88M (-5 808.04 %)
EPS:	SEK-0.230

FY	2022
Ingresos:	SEK12.80M
Beneficio Bruto:	SEK-165.71M (-1 294.89 %)
EPS:	SEK-0.970

FY	2021
Ingresos:	SEK22.41M
Beneficio Bruto:	SEK0.00 (0.00 %)
EPS:	SEK-1.909

Financial Reports:

No articles found.

Isofol Medical AB (publ)

Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer. It has strategic collaborations with Recipharm, Merck & Cie, and Sahlgrenska University Hospital. The company was incorporated in 2008 and is headquartered in Gothenburg, Sweden.